Health
ANTICOV clinical trial to test new treatment for people with mild-to-moderate COVID-19 in Africa – News-Medical.Net
The ANTICOV clinical trial, conducted in 13 African countries, has started the recruitment of participants to test a new drug combination, nitazoxanide + ciclesonide,…
The ANTICOV clinical trial, conducted in 13 African countries, has started the recruitment of participants to test a new drug combination, nitazoxanide + ciclesonide, to treat people with mild-to-moderate COVID-19 before their cases become severe.
The ANTICOV study is being carried out by a consortium of 26 partners which include leading African research institutions and international health organizations, coordinated by the non-profit research and development (R&D) organization Drugs for Neglected…
-
Noosa News17 hours agoPill checking to resume in Queensland months after government axed funding
-
Business20 hours agoWhy Austal, Boss Energy, Harvey Norman, and NextDC shares are charging higher today
-
Business22 hours agoASX shares are expensive. Here’s why you should be buying anyway
-
Noosa News22 hours agoNew Queensland Translink app receives scathing reviews as old app is retired